Skip to main content

Tomorrow Investor

Kobrea Completes Next Payment Under Property Option Agreement for Its Western Malargüe Copper Projects – Mendoza Province, Argentina

Kobrea Secures Western Malargüe Projects with $500,000 Payment | Newsfile Corp

Vancouver, British Columbia–(Newsfile Corp. – August 13, 2026) – Kobrea Exploration Corp. (CSE: KBX) (FSE: F3I) (OTCQB: KBXFF) (“Kobrea” or the “Company”) announces that it has completed the next payment to the optionors under its option agreement dated August 14, 2024 (the “Option Agreement”), pursuant to which the Company has the exclusive right to earn a 100% interest in the seven projects comprising the Western Malargüe Copper Projects, totaling 733 km2 in southwestern Mendoza Province, Argentina (the “Western Malargüe Copper Projects”). The payment consisted of US$500,000 in cash and the issuance of 300,000 common shares of the Company (the “Shares”).

This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.

Brief Summary

Kobrea Exploration Corp. has made a significant stride in its operations regarding the Western Malargüe Copper Projects in Argentina. This announcement highlights the Company’s commitment to advancing its interests in the region.

  • $500,000 payment made to optionors
  • 300,000 common shares issued
  • Exclusive right to earn 100% interest
  • Covers 733 km² in Mendoza Province

Why it matters: This moves Kobrea closer to fully acquiring a strategic asset in a promising copper exploration area.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.